Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients - PubMed (original) (raw)
Controlled Clinical Trial
. 2005 May 17;111(19):2518-24.
doi: 10.1161/01.CIR.0000165070.46111.9F. Epub 2005 May 2.
Affiliations
- PMID: 15867169
- DOI: 10.1161/01.CIR.0000165070.46111.9F
Controlled Clinical Trial
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients
Antonio Ceriello et al. Circulation. 2005.
Abstract
Background: Postprandial hypertriglyceridemia and hyperglycemia are considered risk factors for cardiovascular disease. Evidence suggests that postprandial hypertriglyceridemia and hyperglycemia induce endothelial dysfunction and inflammation through oxidative stress. Statins and angiotensin type 1 receptor blockers have been shown to reduce oxidative stress and inflammation, improving endothelial function.
Methods and results: Twenty type 2 diabetic patients ate 3 different test meals: a high-fat meal, 75 g glucose alone, and a high-fat meal plus glucose. Glycemia, triglyceridemia, endothelial function, nitrotyrosine, C-reactive protein, intercellular adhesion molecule-1, and interleukin-6 were assayed during the tests. Subsequently, diabetics took atorvastatin 40 mg/d, irbesartan 300 mg/d, both, or placebo for 1 week. The 3 tests were performed again between 5 and 7 days after the start of each treatment. High-fat load and glucose alone produced a decrease in endothelial function and increases in nitrotyrosine, C-reactive protein, intercellular adhesion molecule-1, and interleukin-6. These effects were more pronounced when high-fat load and glucose were combined. Short-term atorvastatin and irbesartan treatments significantly counterbalanced these phenomena, and their combination was more effective than either therapy alone.
Conclusions: This study confirms an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial function and inflammation, suggesting oxidative stress as a common mediator of such an effect. Short-term treatment with atorvastatin and irbesartan may counterbalance this phenomenon; the combination of the 2 compounds is most effective.
Similar articles
- Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment.
Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E. Ceriello A, et al. Circulation. 2002 Sep 3;106(10):1211-8. doi: 10.1161/01.cir.0000027569.76671.a8. Circulation. 2002. PMID: 12208795 Clinical Trial. - Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.
Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D. Ceriello A, et al. Diabetes. 2004 Mar;53(3):701-10. doi: 10.2337/diabetes.53.3.701. Diabetes. 2004. PMID: 14988255 Clinical Trial. - Nitrotyrosine: new findings as a marker of postprandial oxidative stress.
Ceriello A. Ceriello A. Int J Clin Pract Suppl. 2002 Jul;(129):51-8. Int J Clin Pract Suppl. 2002. PMID: 12166608 Review. - A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
Matafome P, Nunes E, Louro T, Amaral C, Crisóstomo J, Rodrigues L, Moedas AR, Monteiro P, Cipriano A, Seiça R. Matafome P, et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):241-51. doi: 10.1007/s00210-008-0363-y. Epub 2008 Oct 21. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18936912 - Atherogenicity of postprandial hyperglycemia and lipotoxicity.
Ceriello A, Genovese S. Ceriello A, et al. Rev Endocr Metab Disord. 2016 Mar;17(1):111-6. doi: 10.1007/s11154-016-9341-8. Rev Endocr Metab Disord. 2016. PMID: 26880302 Review.
Cited by
- Blood glucose lowering and anti-oxidant potential of erythritol: An in vitro and in vivo study.
Soetan OA, Ajao FO, Ajayi AF. Soetan OA, et al. J Diabetes Metab Disord. 2023 May 29;22(2):1217-1229. doi: 10.1007/s40200-023-01237-x. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975140 Free PMC article. - Habitual isomaltulose intake reduces arterial stiffness associated with postprandial hyperglycemia in middle-aged and elderly people: a randomized controlled trial.
Kobayashi R, Sakazaki M, Nagai Y, Okamoto T, Hashimoto Y, Sato K, Seki S, Hata U, Esaki K, Tanigawa R, Mitsuoka A, Funaki A, Niki Y, Hashiguchi T, Negoro H. Kobayashi R, et al. Heart Vessels. 2024 Feb;39(2):123-134. doi: 10.1007/s00380-023-02316-y. Epub 2023 Sep 30. Heart Vessels. 2024. PMID: 37777673 Clinical Trial. - Elevated postprandial triglyceride-rich lipoproteins in patients with diabetes and stable coronary artery disease correlated with early renal damage and systemic inflammation.
Guo X, Zhai Y, Song C, Mi Z, Peng J, Guo J, Teng X, Zhang D. Guo X, et al. Lipids Health Dis. 2023 May 3;22(1):58. doi: 10.1186/s12944-023-01820-4. Lipids Health Dis. 2023. PMID: 37138333 Free PMC article. - Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study.
Lee KJ, Ryu JK, Cho YH, Shin WY, Kim JS, Yoon YW, Jang JY, Kim WH, Beom JW, Kang SM; LG-VROS001 STUDY INVESTIGATOR GROUP. Lee KJ, et al. Drug Des Devel Ther. 2023 Apr 6;17:1047-1062. doi: 10.2147/DDDT.S391288. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37051292 Free PMC article. - The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy.
Kostourou DT, Milonas D, Polychronopoulos G, Sofogianni A, Tziomalos K. Kostourou DT, et al. J Pers Med. 2022 Jul 30;12(8):1253. doi: 10.3390/jpm12081253. J Pers Med. 2022. PMID: 36013202 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials